Olmat 20 AMH Tablet
1 Strip of 15 Tablets.Prescription required
About this product:
| Salt Composition: | Olmesartan Medoxomil (20mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg) |
| Manufacturer: | Micro Labs Ltd |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Olmat 20 AMH Tablet is a combination medicine used to treat high blood pressure. Olmat 20 AMH Tablet is used to treat high blood pressure and reduce the risk of heart attack and stroke.
Olmat 20 AMH Tablet works by relaxing blood vessels, reducing blood pressure, and removing excess fluid from the body.
Can I feel dizzy after taking Olmat 20 AMH Tablet?
Yes, dizziness is a common side effect of Olmat 20 AMH Tablet. It is advised to avoid driving or operating machinery if you feel dizzy.
Can I use Olmat 20 AMH Tablet in pregnancy?
No, Olmat 20 AMH Tablet is not recommended during pregnancy as it may harm the unborn baby. Consult your doctor for alternative medications.
What are some lifestyle changes I need to make while using Olmat 20 AMH Tablet?
Lifestyle changes such as maintaining a healthy diet, regular exercise, and avoiding smoking and alcohol can help improve the effectiveness of Olmat 20 AMH Tablet.
How would I know if I have high potassium levels?
Symptoms of high potassium levels include muscle weakness, irregular heartbeat, and nausea. Consult your doctor if you experience these symptoms.
Take Olmat 20 AMH Tablet as directed by your doctor. Swallow it whole with water, preferably at the same time each day.
- Maintain a healthy diet and exercise regularly.
- Avoid smoking and alcohol.
- Monitor your blood pressure regularly.
- Consult your doctor if you experience any side effects.
- Do not stop taking the medicine without consulting your doctor.
- Dizziness
- Headache
- Nausea
- Fatigue
- Swelling of ankles or feet
Alcohol
Avoid alcohol consumption while using this medicine.
Breastfeed
Not recommended for breastfeeding mothers.
Pregnancy
Not recommended during pregnancy.
